The first trilogue negotiations between EU lawmakers over the long-awaited reform to Europe’s pharmaceutical legislation will ...

BeOne Medicines (NASDAQ:ONC) gains FDA approval for a new tablet version of Brukinsa, simplifying dosage for patients.

Softgel capsules—the smooth, easy-to-swallow form of many medications and supplements—are increasingly popular for delivering ...

A European health authority has found that medications containing semaglutide—such as Ozempic, Wegovy, and Rybelsus—can ...

The University of Oxford has received support from European Medicines Agency's (EMA) for its vaccine targeting the deadly ...

BOSTON & MONTREAL, June 12, 2025--enGene Holdings Inc. (Nasdaq: ENGN, or "enGene" or the "Company"), a clinical-stage, ...

An international clinical trial, led in the UK by Swansea’s Joint Clinical Research Facility (JCRF), has found that ...

NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), an artificial intelligence (AI) solutions company transforming clinical trial design in the ...

FDA approves new Brukinsa tablet for five blood cancers, offering simpler dosing with the same safety and effectiveness as ...

DEP, the most common plasticiser in softgels, is considered to have relatively low toxicity and is used in small amounts. The ...

The OSOA package creates a common platform that integrates existing databases and offers a 'one-stop shop' for chemical data from EU agencies and the Commission. It enables knowledge sharing from one ...

The European Union (EU) is actively courting biotech for economic growth and has launched several initiatives to attract ...